CN102327319B - Mint liquidity tablet and preparation method thereof - Google Patents
Mint liquidity tablet and preparation method thereof Download PDFInfo
- Publication number
- CN102327319B CN102327319B CN 201110267318 CN201110267318A CN102327319B CN 102327319 B CN102327319 B CN 102327319B CN 201110267318 CN201110267318 CN 201110267318 CN 201110267318 A CN201110267318 A CN 201110267318A CN 102327319 B CN102327319 B CN 102327319B
- Authority
- CN
- China
- Prior art keywords
- tablet
- mint
- liquidity
- temperature
- low
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000006679 Mentha X verticillata Nutrition 0.000 title claims abstract description 83
- 235000002899 Mentha suaveolens Nutrition 0.000 title claims abstract description 83
- 235000001636 Mentha x rotundifolia Nutrition 0.000 title claims abstract description 83
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000000843 powder Substances 0.000 claims abstract description 60
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000008187 granular material Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 21
- 238000007908 dry granulation Methods 0.000 claims description 14
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 27
- 229940079593 drug Drugs 0.000 abstract description 13
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 239000000341 volatile oil Substances 0.000 abstract description 10
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000003825 pressing Methods 0.000 abstract 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 22
- 238000005303 weighing Methods 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000012856 packing Methods 0.000 description 6
- 238000000227 grinding Methods 0.000 description 5
- 238000005286 illumination Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229940041616 menthol Drugs 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 206010021703 Indifference Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000004454 trace mineral analysis Methods 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000011802 pulverized particle Substances 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a mint liquidity tablet and a preparation method thereof. The mint liquidity tablet aims to solve the problems that the traditional mint tablet has huge size and can not realize automatic package; and when the traditional mint tablet is stored for more than 3 months, the content of volatile oil of the traditional mint tablet is hard to reach the standard regulated in the pharmacopoeia. The preparation method comprises the following steps of: taking the traditional mint tablet as raw materials, crushing at a low temperature to obtain mint low-temperature powder with a grain size of 50-100 meshes, firstly pressing the mint low-temperature powder into a primary big tablet with a diameter of 16-25 mm, then pressing the primary big tablet after being crushed, sieved andgranulated into a tablet with a diameter of 4-12 mm, namely the mint liquidity tablet. The mint liquidity tablet has the beneficial effects that the drug property of the mint liquidity tablet is not changed and conforms to the traditional Chinese medicine theory; the mint liquidity tablet has stable quality and small size, on which the hygienic indexes and the shelf cycle are provided; and the mint liquidity tablet is basically consistent with the traditional tablet in pharmaceutical indexes, is convenient to store, can realize mechanical and automatic small package and has accurate dosage; and the production process conforms to the requirements of modern large-scale production, therefore, the mint liquidity tablet is suitable for industrialization promotion.
Description
Technical field
The present invention relates to the processing technique of Chinese herbs field, particularly a kind of mint liquidity tablet and preparation method thereof.
Background technology
The prepared slices of Chinese crude drugs are Chinese crude drugs through by Chinese medical theory, Chinese medicine processing method, after concocting through processing, can be directly used in the Chinese medicine of tcm clinical practice.The prepared slices of Chinese crude drugs are characteristics of Chinese medicine, are that the traditional Chinese medical science is directly used in clinical prescriptions according to the determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs principle, are again the raw materials of preparation Chinese patent medicine.
The development course of the prepared slices of Chinese crude drugs from ancestors' " mouth is chewed " the earliest, to the application of the Bronze Age cutting instrument, keeps the physical state of pieces of cutting so far.Particularly careless class and flower class are bulky, are difficult to store and packing, do not have the shelf cycle, do not have Hygienic Index.Along with the progress of modern science and technology, need to change the prepared slices of Chinese crude drugs.In recent years, State Administration of Traditional Chinese Medicine proposes and promotes the use of the fractional pack prepared slices of Chinese crude drugs, has changed the conventional formulation pattern of the prepared slices of Chinese crude drugs, and the production of the prepared slices of Chinese crude drugs is had higher requirement.At present, only have evengranular decoction pieces just can realize the mechanization fractional pack, huge as careless class, flower class equal-volume, production process is craft, has strengthened production cost and workload.
The direction of at present preparing new-type medical herbs drink tablets exploration mainly contains: the new models such as Chinese medicinal granule decoction pieces, powder-type (ultra-micro powder) decoction pieces.The Chinese medicinal granule decoction pieces is effective component extracting from the single medicinal material decoction pieces, through being processed into concentrated granular; Powder-type (ultra-micro powder) decoction pieces, its instructions of taking mainly are that single medicinal material material ultramicro powder is placed in the boiled water and takes after soaking a few minutes, or swallow.The disclosure of the Invention of publication number CN1362059A a kind of Nano Chinese medicine piece and preparation method thereof, Chinese medicine powder is broken into fine powder, be ground into superfine powder below 500 nanometers with jet mill subsequently.The preparation cost of this superfine powder is high, and has broken the cell wall of plant or Animal Medicine during preparation, has than big difference with the structure of Chinese medicine decoction pieces, and the effect same that whether can reach the Chinese medicine decoction pieces needs checking.Simultaneously, the granularity of this superfine powder is too tiny, and is mobile unstable, if realize automatization's weighing, minute packing by equipment such as pipelines, is easy to cause line clogging.
Herba Menthae is the careless class Chinese medicine of commonly using, and its main component is volatile oil, and traditional Herba Menthae decoction pieces is bulky, can't realize automatic packaging, preserves more than 3 months, and its volatile oil content is difficult to reach the pharmacopeia specified standard.
Summary of the invention
It is bulky to the object of the invention is to solve traditional Herba Menthae decoction pieces, can't realize automatic packaging, preserve more than 3 months, its volatile oil content is difficult to reach the problem of pharmacopeia specified standard, a kind of mint liquidity tablet is provided, and its property of medicine does not change, and meets Chinese medical theory, and steady quality, volume is little, and Hygienic Index is arranged, and the shelf cycle is arranged, pharmacy index and traditional decoction pieces are basically identical, the convenient storage can be realized the mechanical automation fractional pack, and dosage is accurate, production technology meets the large requirement of producing of modernization, is fit to Industry Promotion.
Another object of the present invention is to provide a kind of preparation method of mint liquidity tablet.
The technical solution adopted for the present invention to solve the technical problems is: a kind of mint liquidity tablet, described mint liquidity tablet is take traditional Herba Menthae decoction pieces as raw material, process to get granularity 60～100 purpose Herba Menthae low-temperature powders through pulverize at low temperature, the Herba Menthae low-temperature powder is pressed into first the elementary sheet of diameter 16～25mm, elementary sheet is through pulverizing, sieve, behind the granulate repress make diameter 4～12mm tablet be mint liquidity tablet.
Tradition Herba Menthae decoction pieces is a kind of prepared slices of Chinese crude drugs, the present invention is according to the Manufacture of medicinal slices of TCM actual demand, follow traditional Chinese medicine theory, develop a kind of preparing new-type medical herbs drink tablets (mint liquidity tablet) in conjunction with the modern pharmaceutical technology, to reach reliable and stable, the automatic packaging of About The Quality of Sliced Herbal Medicine, satisfy the requirement of prepared slices of Chinese crude drugs industrialization.
The present invention utilizes the Herba Menthae low-temperature powder first, adopts compressing dry granulation, does not add any adjuvant, is prepared into mint liquidity tablet of the present invention.Be easy to preserve the effumability composition in the Herba Menthae, the sheet type is good, and hardness is moderate, big or small homogeneous, and even density, good fluidity is suitable for quantitative automaticization packing and preservation.Mint liquidity tablet is circular tablet.
Once adopted wet granulation to make mint liquidity tablet (ball blast) in the process of the test of the present invention, qualitative, quantitative by mint liquidity tablet ball blast and Tabules and traditional decoction pieces is relatively learnt: mint liquidity tablet of the present invention more can keep involatile constituent in Oleum menthae and the decocting liquid than the ball blast dosage form, so mint liquidity tablet preparation technology is the dry granulation tabletting.
As preferably, the temperature that pulverize at low temperature is processed is-15～0 ℃.
As preferably, the grain graininess behind the granulate is 18～60 orders.It is moderate to process like this mint liquidity tablet hardness that obtains, even density, and good fluidity is suitable for quantitative automaticization packing and preservation.
As preferably, the ratio of granularity 80 purpose Herba Menthae low-temperature powders is more than 80% in the Herba Menthae low-temperature powder.
A kind of preparation method of mint liquidity tablet, described preparation method step is as follows:
(1) pulverize at low temperature
Traditional Herba Menthae decoction pieces pulverize at low temperature in the superfine comminution at low temperature machine is processed, got granularity 60～100 purpose Herba Menthae low-temperature powders;
Grinding particle size and grinding time are proportional, can regulate grinding particle size by the control grinding time;
(2) dry granulation tabletting
The Herba Menthae low-temperature powder that step (1) obtains is poured in the rotary tablet machine, the pressure of adjusting rotary tablet machine is 20～60N, rotating speed is 10～20r/min, suppress to get the elementary sheet of diameter 16～25mm, then elementary sheet is poured in the swing pulverizer and pulverized, sieve, granulate, get granularity 18～60 purpose granules, again granularity 18～60 purpose granules are poured in the rotary tablet machine, the pressure of adjusting rotary tablet machine is 15～30N, and rotating speed is 30～60r/min, suppresses to such an extent that the tablet of diameter 4～12mm is mint liquidity tablet.
As preferably, the temperature that step (1) pulverize at low temperature is processed is-15～0 ℃.
Herba Menthae is the effumability medical material, and the Ordinary pulverization machine is pulverized Herba Menthae, because the crushing process heat production causes loss of volatile oil; In addition, pulverized particles is inhomogeneous.The superfine comminution at low temperature machine carries temperature control system, the adjustable temperature scope be-30 ℃ to room temperature.As long as prerun is found temperature below 0 ℃, and different temperatures is not obvious to volatile oil and particle size influences, so consider energy-saving and cost-reducingly, we determine that the set temperature scope is-15～0 ℃.
As preferably, the Herba Menthae low-temperature powder that step (1) obtains, wherein the ratio of granularity 80 purpose Herba Menthae low-temperature powders is more than 80%.Granularity 80 purpose Herba Menthae low-temperature powders are in the majority, are beneficial to so follow-up dry granulation tabletting, guarantee product quality.
As preferably, the crushing bin of step (1) superfine comminution at low temperature machine is totally-enclosed.The advantage of processing like this is: reduce the medical material loss, keep the production environment cleaning.
As preferably, control the relative humidity of operating environment in the whole preparation process of mint liquidity tablet less than 65%.The relative humidity of control operation environment is stablized non-hygroscopic less than 65% to guarantee the Herba Menthae low-temperature powder.
The invention has the beneficial effects as follows:
1, utilizes first the Herba Menthae low-temperature powder, adopt compressing dry granulation, do not add any adjuvant, be prepared into mint liquidity tablet of the present invention.Be easy to preserve the effumability composition in the Herba Menthae, the sheet type is good, and hardness is moderate, big or small homogeneous, and even density, good fluidity is suitable for quantitative automaticization packing and preservation.
2, the property of medicine does not change, meet Chinese medical theory, and steady quality, volume is little, Hygienic Index is arranged, the shelf cycle is arranged, and pharmacy index and traditional decoction pieces are basically identical, the convenient storage, can realize the mechanical automation fractional pack, dosage is accurate, and production technology meets the large requirement of producing of modernization, is fit to Industry Promotion.
Description of drawings
Fig. 1 is traditional Herba Menthae decoction pieces;
Fig. 2 is mint liquidity tablet of the present invention;
Fig. 3 is Herba Menthae low-temperature powder moisture equilibrium at dry side curve;
Fig. 4 is traditional Herba Menthae decoction pieces and mint liquidity tablet thin-layer chromatogram of the present invention;
Fig. 5 is traditional Herba Menthae decoction pieces and mint liquidity tablet GC mirror image collection of illustrative plates of the present invention;
Fig. 6 is traditional Herba Menthae decoction pieces and mint liquidity tablet decocting liquid HPLC mirror image collection of illustrative plates of the present invention.
The specific embodiment
Below by specific embodiment, and by reference to the accompanying drawings, technical scheme of the present invention is described in further detail.
Embodiment 1
(1) pulverize at low temperature
Traditional Herba Menthae decoction pieces pulverize at low temperature in CW-12 superfine comminution at low temperature machine is processed, the crushing bin of superfine comminution at low temperature machine is totally-enclosed, the temperature that pulverize at low temperature is processed is-15 ℃, pulverized first 6 minutes, sieve, to not pulverize 5 minutes by part again, and get granularity 60～100 purpose Herba Menthae low-temperature powders, the ratio of granularity 80 purpose Herba Menthae low-temperature powders is more than 80% in the Herba Menthae low-temperature powder.
(2) dry granulation tabletting
The Herba Menthae low-temperature powder that step (1) obtains is poured in the ZP-7 rotary tablet machine, the punch diameter of rotary tablet machine is 16mm, the pressure of adjusting rotary tablet machine is 20N, rotating speed is 10r/min, suppress to get the elementary sheet of diameter 16mm, then elementary sheet is poured in the swing pulverizer and pulverized, sieve, granulate gets granularity 18～60 purpose granules, granularity 18～60 purpose granules is poured in the rotary tablet machine again, the punch diameter of rotary tablet machine is 4mm, the pressure of adjusting rotary tablet machine is 15N, and rotating speed is 30r/min, suppresses to such an extent that the circular tablet of diameter 4mm is mint liquidity tablet.
The relative humidity of operating environment is less than 65% in the whole preparation process of control mint liquidity tablet.
Embodiment 2
(1) pulverize at low temperature
Traditional Herba Menthae decoction pieces pulverize at low temperature in CW-12 superfine comminution at low temperature machine is processed, the crushing bin of superfine comminution at low temperature machine is totally-enclosed, the temperature that pulverize at low temperature is processed is-10 ℃, pulverized first 7 minutes, sieve, to not pulverize 4 minutes by part again, and get granularity 60～100 purpose Herba Menthae low-temperature powders, the ratio of granularity 80 purpose Herba Menthae low-temperature powders is more than 80% in the Herba Menthae low-temperature powder.
(2) dry granulation tabletting
The Herba Menthae low-temperature powder that step (1) obtains is poured in the ZP-7 rotary tablet machine, the punch diameter of rotary tablet machine is 20mm, the pressure of adjusting rotary tablet machine is 40N, rotating speed is 15r/min, suppress to get the elementary sheet of diameter 20mm, then elementary sheet is poured in the swing pulverizer and pulverized, sieve, granulate gets granularity 18～60 purpose granules, granularity 18～60 purpose granules is poured in the rotary tablet machine again, the punch diameter of rotary tablet machine is 6mm, the pressure of adjusting rotary tablet machine is 20N, and rotating speed is 40r/min, suppresses to such an extent that the circular tablet of diameter 6mm is mint liquidity tablet.
The relative humidity of operating environment is less than 65% in the whole preparation process of control mint liquidity tablet.
Embodiment 3
(1) pulverize at low temperature
Traditional Herba Menthae decoction pieces pulverize at low temperature in CW-12 superfine comminution at low temperature machine is processed, the crushing bin of superfine comminution at low temperature machine is totally-enclosed, the temperature that pulverize at low temperature is processed is 0 ℃, pulverized first 6 minutes, sieve, to not pulverize 5 minutes by part again, and get granularity 60～100 purpose Herba Menthae low-temperature powders, the ratio of granularity 80 purpose Herba Menthae low-temperature powders is more than 80% in the Herba Menthae low-temperature powder.
(2) dry granulation tabletting
The Herba Menthae low-temperature powder that step (1) obtains is poured in the ZP-7 rotary tablet machine, the punch diameter of rotary tablet machine is 25mm, the pressure of adjusting rotary tablet machine is 60N, rotating speed is 20r/min, suppress to get the elementary sheet of diameter 25mm, then elementary sheet is poured in the swing pulverizer and pulverized, sieve, granulate gets granularity 18～60 purpose granules, granularity 18～60 purpose granules is poured in the rotary tablet machine again, the punch diameter of rotary tablet machine is 12mm, the pressure of adjusting rotary tablet machine is 30N, and rotating speed is 60r/min, suppresses to such an extent that the circular tablet of diameter 12mm is mint liquidity tablet.
The relative humidity of operating environment is less than 65% in the whole preparation process of control mint liquidity tablet.
Grinding time can be adjusted according to demand.
The form of tradition Herba Menthae decoction pieces and mint liquidity tablet of the present invention is seen Fig. 1, Fig. 2.
The raw material determination of physical appearance
(1) the Herba Menthae low-temperature powder refers to free inclined-plane and the formed maximum angular of horizontal plane of powder body accumulation horizon angle of repose angle of repose.Angle of repose is less, and frictional force is less, and flowability is better.
The method of measuring angle of repose has two kinds: injection method and discharge method.The present invention adopts injection method to measure the angle of repose of powder and tablet.
H: height, r: radius, θ: angle of repose
The flowability of powder body is larger on weight differential and the normal operating impact of the preparations such as granule, capsule, tablet.Record the angle of repose of Herba Menthae low-temperature powder according to injection method greater than 40 degree, directly compressing dry granulation needs dry granulation, again tabletting.
(2) Herba Menthae low-temperature powder hygroscopicity is put into the accurately weighing of flat weighing botle (about 1.0g) that is dried to constant weight with the Herba Menthae low-temperature powder, then places in the exsiccator of different salt supersaturated solutions, preserves 5 days in 25 ℃ of calorstats.Calculate the moisture absorption percentage rate.The hydroscopicity computing formula is as follows:
Take hydroscopicity as vertical coordinate, relative humidity is the abscissa mapping.Two places make tangent line at curve, and the abscissa of two points of intersection of tangents is the critical relative humidity of Herba Menthae low temperature medicated powder, the results are shown in Figure 3.
As shown in Figure 3, the critical relative humidity of Herba Menthae low-temperature powder is about 65%, shows ambient humidity greater than 65% the time, and its hygroscopic capacity can increase sharply.Therefore it is non-hygroscopic to keep the Herba Menthae low-temperature powder to stablize, and requires the relative humidity in control workshop in preparation process less than 65%.
The finished product evaluation of mint liquidity tablet
Take the tablet of diameter 6mm as example
(1) weight differential is according to 2010 editions one one of Chinese Pharmacopoeia, and appendix ID tablet weight variation method checks that the heavy 0.0745g of average sheet meets tablet weight variation limit ± 7.5%.
(2) friability is got 1g, blows away the powder that comes off with hair-dryer, and precise weighing is put in the friabilator, rotates 100 times.Take out, remove powder with method, precise weighing subtracts weight loss/former weight * 100%, calculates friability.The friability of Herba Menthae dry granulation tabletting is 0.8517%.
(3) leach the time and get and make mint liquidity tablet 10g, add in the boil water and stir, required time when measuring complete decoction made from powder, it is complete to record all in 5min decoction made from powder.
(4) bulk density takes by weighing a certain amount of tablet (m), places the 10mL graduated cylinder, fall from distance 5cm, and continued operation 3 times, the measured quantity cylindrical shell amasss (V), and it is 0.4806g/ml that bulk density (d) is obtained bulk density by formula d=m/V.
The factors influencing of mint liquidity tablet preparation method
With pressure (A), revolution (B), Herba Menthae low-temperature powder granularity (C) is main investigation factor, each factor sets up 3 levels separately, adopts orthogonal table L
9(3
4) arrangement test (table 1).Pressure, revolution, Herba Menthae low-temperature powder granularity done find that each factor level is little to the Herba Menthae Haplocalycis volatile oil content influence when single factor is investigated, thus only take granule yield and angle of repose as evaluation index, integrated survey Herba Menthae dry granulation tablet forming technique.
Table 1 factor level
The result shows, comprehensive granule yield and angle of repose result of the test, so the optimum process that draws the Herba Menthae dry granulation is for being A
2B
1C
2Namely utilize 80 order Herba Menthae low-temperature powders, adjusting tablet machine pressure is 40N, and rotating speed is 10r/min.And pass through demonstration test.
The comparison of mint liquidity tablet and traditional Herba Menthae decoction pieces
(1) microscopic features are differentiated
By the microscopic features of traditional Herba Menthae decoction pieces and two kinds of samples of mint liquidity tablet of the present invention are differentiated that the result shows: all can find out conduit, hesperidin crystal, pore, little glandular hair, nonglandular hair and glandular scale in two kinds of samples of traditional Herba Menthae decoction pieces and mint liquidity tablet of the present invention.Show that traditional Herba Menthae decoction pieces and mint liquidity tablet microscopic features of the present invention are without significant difference.
(2) thin layer chromatography is differentiated
As shown in Figure 4: all can detect Mentholum in traditional Herba Menthae decoction pieces and the mint liquidity tablet of the present invention.Both thin layer chromatographys are differentiated without marked difference.Instrument: REPROSTAR 3 laminagraphy systems (Camag company).
(3) water content, total ash and acid-insoluble ash are measured and are seen Table 2
The measurement result of the moisture of table 23 batch traditional Herba Menthae decoction pieces, mint liquidity tablet of the present invention, total ash, acid-insoluble ash
| The decoction pieces kind | Moisture (%) | Total ash (%) | Acid-insoluble ash (%) |
| Tradition | 11.0 | 6.39 | 0.33 |
| Mint liquidity tablet | 9.50 | 6.12 | 0.21 |
(4) the total quantitative determination of Oleum menthae sees Table 3
The traditional Herba Menthae decoction pieces of table 3 and mint liquidity tablet volatile oil of the present invention and moisture are relatively
| Tradition Herba Menthae decoction pieces | Mint liquidity tablet | |
| Herba Menthae oil mass (%) | 1.10 | 0.95 |
| Moisture (%) | 11.0 | 9.5 |
| In dry product Herba Menthae oil mass (%) | 1.23 | 1.05 |
Determination of volatile oil: 2010 Chinese Pharmacopoeias appendix XD determination of volatile oil Division A League Matches of French Football method must not be less than 0.40%
Determination of water: an appendix IX of 2010 Chinese Pharmacopoeias H the second method toluene method must not be crossed 13.0% result and show: mint liquidity tablet of the present invention and traditional Herba Menthae decoction pieces Herba Menthae oil mass are more or less the same.
(5) volatile ingredient GC trace analysis
As shown in Figure 5: mint liquidity tablet of the present invention and traditional Herba Menthae decoction pieces volatile ingredient be indifference almost.
(6) composition HPLC trace analysis in the aqua methnae decocting liquid
As shown in Figure 6: mint liquidity tablet of the present invention and traditional Herba Menthae decoction pieces decocting liquid composition be indifference almost.
The estimation of stability of mint liquidity tablet of the present invention
(1) hot test
Get mint liquidity tablet of the present invention, put in the hermetically drying device, under 60 ℃ of conditions, placed 10 days, in sampling in 0,5,10 day, detect according to test item.The results are shown in Table 4-1, the result shows that this product is at high temperature placed, and is with comparison in 0 day, test item generation significant change, stable not to heat.Test with method under 40 ℃ with batch mint liquidity tablet of the present invention.The results are shown in Table 4-2.
Show to place under the 4-160 ℃ of condition 10 days hot test results
Show to place under the 4-240 ℃ of condition 10 days hot test results
The result shows: placed 10 days under 60 ℃ of conditions, Determination of menthol significantly reduces, and illustrates that mint liquidity tablet of the present invention is responsive to heat, places 10 days under 40 ℃ of conditions, and Determination of menthol also has a small amount of minimizing.
(2) high wet test
Get mint liquidity tablet of the present invention and put into the accurately weighing of flat weighing botle that is dried to constant weight, place respectively in the exsiccator of supersaturation sodium chloride solution (25 ℃, RH75% ± 5%) and supersaturation potassium nitrate solution (25 ℃, RH92.5% ± 5%).
Under 25 ℃, RH92.5% ± 5% condition, placed 10 days, detect sampling in 0,5,10 day.Test item should comprise moisture absorption weightening finish etc.If moisture absorption weightening finish is more than 5%, then should time test with method at 25 ℃, RH75% ± 5%; If moisture absorption weightening finish is below 5%, and other investigation projects meet the requirements, and then no longer carry out this test.The results are shown in Table 5-1,5-2.
Show to place under 5-125 ℃, RH92.5% ± 5% condition 10 days high humidity result of the tests
Show to place under 5-225 ℃, RH75% ± 5% condition 10 days high humidity result of the tests
The result shows: placed 10 days under 25 ℃, RH92.5% ± 5% condition, moisture absorption is increased weight up to 27.12%, more than 5%, then time tests with method at 25 ℃, RH75% ± 5%, and moisture absorption is increased weight below 5%, and other investigation projects meet the requirements.
(3) strong illumination test
Getting mint liquidity tablet of the present invention, put and be equipped with in the illumination container that illumination is 4500lx ± 500lx daylight lamp, is to place 10 days under 4500lx ± 500lx condition in illumination, detects sampling in 0,5,10 day.Should note controlling temperature in the test, be consistent with room temperature, and note observing the cosmetic variation of test sample.The results are shown in Table 6.
The result shows: mint liquidity tablet of the present invention is under strong illumination, and character and discriminating are all unchanged, and Determination of menthol has a small amount of variation, and visible high light is not very large on mint liquidity tablet impact of the present invention.
(4) accelerated stability test
Get Zhejiang and produce traditional Herba Menthae decoction pieces and mint liquidity tablet of the present invention, plastic bag packaging, because of this product to thermo-responsive, place to place under 30 ± 2 ℃ of intelligent growth cabinets, RH65% ± 5% condition and tested in 3 months, detect 3 months stability experiment data such as following table 7 respectively at sampling in 0,1,2,3 month.
3 months experimental datas of acceleration of the traditional Herba Menthae decoction pieces of table 7 and mint liquidity tablet of the present invention
The result can find out: by the trimestral acceleration experiment of three batches of traditional Herba Menthae decoction pieces and mint liquidity tablet of the present invention, find that mint liquidity tablet of the present invention is every to have no significant change, and the Determination of menthol of traditional Herba Menthae decoction pieces has to descend and accelerates.3 months accelerated test thinks that the stability of mint liquidity tablet of the present invention should be better than traditional Herba Menthae decoction pieces.
Conclusion
Pass through stability test, investigate mint liquidity tablet of the present invention in the lower time dependent rule of medicine characteristic of varying environment condition (such as temperature, humidity, light etc.), show that mint liquidity tablet of the present invention is more stable to light, find that temperature and humidity are larger to the stability influence of mint liquidity tablet of the present invention, for pharmaceutical production, packing, storage, traffic condition determine and the foundation of effect duration provides scientific basis.The effect duration of mint liquidity tablet of the present invention can reach about 2 years.
Above-described embodiment is a kind of better scheme of the present invention, is not that the present invention is done any pro forma restriction, also has other variant and remodeling under the prerequisite that does not exceed the technical scheme that claim puts down in writing.
Claims (6)
1. mint liquidity tablet, it is characterized in that: described mint liquidity tablet is take traditional Herba Menthae decoction pieces as raw material, process to get granularity 60 ~ 100 purpose Herba Menthae low-temperature powders through pulverize at low temperature, the Herba Menthae low-temperature powder is pressed into first the elementary sheet of diameter 16 ~ 25mm, elementary sheet is through pulverizing, sieve, behind the granulate repress make diameter 4 ~ 12mm tablet be mint liquidity tablet; The temperature that pulverize at low temperature is processed is-15～0 ℃; Grain graininess behind the granulate is 18 ~ 60 orders; The ratio of granularity 80 purpose Herba Menthae low-temperature powders is more than 80% in the Herba Menthae low-temperature powder.
2. the preparation method of a mint liquidity tablet, it is characterized in that: described preparation method step is as follows:
(1) pulverize at low temperature
Traditional Herba Menthae decoction pieces pulverize at low temperature in the superfine comminution at low temperature machine is processed, got granularity 60 ~ 100 purpose Herba Menthae low-temperature powders;
(2) dry granulation tabletting
The Herba Menthae low-temperature powder that step (1) obtains is poured in the rotary tablet machine, the pressure of adjusting rotary tablet machine is 20 ~ 60N, rotating speed is 10 ~ 20 r/min, suppress to get the elementary sheet of diameter 16 ~ 25mm, then elementary sheet is poured in the swing pulverizer and pulverized, sieve, granulate, get granularity 18 ~ 60 purpose granules, again granularity 18 ~ 60 purpose granules are poured in the rotary tablet machine, the pressure of adjusting rotary tablet machine is 15 ~ 30N, and rotating speed is 30 ~ 60 r/min, suppresses to such an extent that the tablet of diameter 4 ~ 12mm is mint liquidity tablet.
3. preparation method according to claim 2 is characterized in that: the temperature that step (1) pulverize at low temperature is processed is-15～0 ℃.
4. according to claim 2 or 3 described preparation methoies, it is characterized in that: the Herba Menthae low-temperature powder that step (1) obtains, wherein the ratio of granularity 80 purpose Herba Menthae low-temperature powders is more than 80%.
5. according to claim 2 or 3 described preparation methoies, it is characterized in that: the crushing bin of step (1) superfine comminution at low temperature machine is totally-enclosed.
6. it is characterized in that according to claim 2 or 3 described preparation methoies: the relative humidity of operating environment is less than 65% in the whole preparation process of control mint liquidity tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110267318 CN102327319B (en) | 2011-09-09 | 2011-09-09 | Mint liquidity tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110267318 CN102327319B (en) | 2011-09-09 | 2011-09-09 | Mint liquidity tablet and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102327319A CN102327319A (en) | 2012-01-25 |
| CN102327319B true CN102327319B (en) | 2013-04-03 |
Family
ID=45479449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110267318 Active CN102327319B (en) | 2011-09-09 | 2011-09-09 | Mint liquidity tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102327319B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102914482B (en) * | 2012-08-30 | 2015-10-07 | 山东淄博新达制药有限公司 | Cefaclor particle manufacture control method |
| CN103349679A (en) * | 2013-06-08 | 2013-10-16 | 浙江中医药大学中药饮片有限公司 | Mulberry leaf fluid decoction tablets and preparation method thereof |
| CN103385904B (en) * | 2013-06-13 | 2015-06-03 | 浙江中医药大学 | Chrysanthemum decocting pill and preparation process thereof |
| CN104432214A (en) * | 2013-09-24 | 2015-03-25 | 修运庆 | Sea cucumber buccal tablets |
| CN105194199A (en) * | 2015-09-21 | 2015-12-30 | 贵州贵龙中药材科技有限公司 | Sub-health Chinese herb flowability decoction pieces and preparing method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2091716U (en) * | 1991-02-04 | 1992-01-01 | 浙江大学 | Low-temp. pulverizer of dipped chinese herbal medicines |
-
2011
- 2011-09-09 CN CN 201110267318 patent/CN102327319B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2091716U (en) * | 1991-02-04 | 1992-01-01 | 浙江大学 | Low-temp. pulverizer of dipped chinese herbal medicines |
Non-Patent Citations (4)
| Title |
|---|
| 中药饮片与其加工设备沿革的探讨;杨俊杰等;《时珍国医国药》;20100430;第21卷(第4期);第925-926页 * |
| 张云等.一种新型中药饮片——流动性饮片的研制.《中华中医药学会中药炮制分会2008年学术研讨会论文集》.2008,第221页第21-31行，第221-223页"1生产工艺研究"项下，第222页图1. |
| 张云等.一种新型中药饮片——流动性饮片的研制.《中华中医药学会中药炮制分会2008年学术研讨会论文集》.2008,第221页第21-31行,第221-223页"1生产工艺研究"项下,第222页图1. * |
| 杨俊杰等.中药饮片与其加工设备沿革的探讨.《时珍国医国药》.2010,第21卷(第4期),第925-926页. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102327319A (en) | 2012-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327319B (en) | Mint liquidity tablet and preparation method thereof | |
| CN104876947B (en) | Cefetamet Pivoxil Hydrochloride hydrate crystal and its dispersible tablet | |
| CN103969372B (en) | A kind of assay of capsule for protecting heart and discrimination method | |
| CN107951848A (en) | A kind of Afatinib tablet composition | |
| CN102406674B (en) | Centella asiatica (L.) Urban fluid decoction pieces and preparation method thereof | |
| CN102406760B (en) | Herba verbenae officinalis fluid decoction pieces and preparation method thereof | |
| CN106727369B (en) | Dequalinium chloride buccal tablet and preparation method thereof | |
| CN1857445B (en) | Quality control method for Desheng preparation | |
| CN102813699B (en) | Pharmaceutical composition having effects of heat clearing, detoxifying and anti-inflammation and preparation method thereof | |
| CN1957987B (en) | Medicine preparation for treating infectious diseases, preparation method, and quality detection method | |
| CN103860520A (en) | Moxifloxacin capsules, and preparation method thereof | |
| CN114288256A (en) | Preparation method of sugar-free tablet for treating enteritis | |
| CN105145957A (en) | Health herbal tea for treating oral ulcer, preparation method of health herbal tea and detection method | |
| CN103356796B (en) | Blood stasis removing particles and preparation method thereof | |
| CN102920893A (en) | Fifteen-component alplily eyesight improving tablet and preparation process thereof | |
| CN110568109A (en) | Method for screening radix peucedani feeding materials in lung ventilating and regulating preparation by adopting HPLC (high performance liquid chromatography) | |
| CN105434381A (en) | Chloramphenicol tablet preparation method, chloramphenicol tablet, and applications thereof | |
| CN105203474A (en) | Detection method of traditional Chinese medicine health care preparation for protecting chemical liver injuries | |
| CN105395956B (en) | A Chinese medicinal composition for treating wind-heat type common cold, and its preparation method and quality control method | |
| CN103919822B (en) | Compound brucea javanica oil softgel | |
| CN106334100A (en) | Gastrodia elata superfine powder, and preparation method and use of gastrodia elata superfine powder | |
| CN113440571B (en) | Preparation method of kidney-tonifying and bone-strengthening capsule | |
| CN102764236A (en) | Matrine granules and preparation method thereof | |
| TWI435736B (en) | Process of adding catalyst to soup containing four chinese herbal substances for women and effect | |
| CN101129471A (en) | Quality control method of south schizandrol extract oral solid formulated product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB02 | Change of applicant information |
Address after: 311401, No. 3, No. 17, Dongzhou industrial function zone, Hangzhou, Zhejiang, Fuyang Applicant after: Zhejiang Chinese Medical University Medical Pieces Co.,Ltd. Address before: 311401, No. 3, No. 17, Dongzhou industrial function zone, Hangzhou, Zhejiang, Fuyang Applicant before: Traditional Chinese Medicinal Tablet Factory, Zhejiang University of Traditional Chinese Medicine |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: CHINESE HERBAL PIECES FACTORY OF ZHEJIANG CHINESE MEDICAL UNIVERSITY TO: ZHEJIANG CHINESE MEDICAL UNIVERSITY MEDICAL PIECES LTD. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |